Japan Diabetes Outcome Intervention Trial 1(J-DOIT1) : Intervention study to prevent or delay type 2 diabetes mellitus

Conditions

Impaired Fasting Glucose

Naoki Sakane, Yoshitake Oshima, Kazuhiko Kotani, Akiko Suganuma, Shinsuke Nirengi et al. (12 authors)

BMC Research Notes2020-08-081 citations

Prevention of Metabolic Syndrome by Telephone-Delivered Lifestyle Intervention in a Real-World Setting: Sub-Analysis of a Cluster-Randomized Trial

Naoki Sakane, Kazuhiko Kotani, Akiko Suganuma, Kaoru Takahashi, Juichi Sato et al. (11 authors)

Metabolic Syndrome and Related Disorders2019-05-308 citations

10.1089/met.2018.0130

Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial

Naoki Sakane, Kazuhiko Kotani, Kaoru Takahashi, Yoshiko Sano, Kokoro Tsuzaki et al. (15 authors)

BMJ Open2015-08-0142 citations

10.1136/bmjopen-2014-007316

Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: rationale, design, and recruitment.

Sakane N, Kotani K, Takahashi K, Sano Y, Tsuzaki K, Okazaki K, Sato J, Suzuki S, Morita S, Izumi K, Kato M, Ishizuka N, Noda M, Kuzuya H.

2013-01-297 citations

10.1186/1471-2458-13-81

Interventions

&quot

Diabetes Prevention Support&quot

, which is a health care support about diet and exercise mainly via phone call, provided by support service center. Usual health care support using newsletter.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) fasting blood glucose >/=100mg/dl and <126mg/dl 2) casual blood glucose >/=118mg/dl and <144mg/dl

Exclusion criteria

Exclusion criteria: 1) persons with a previous diagnosis of diabetes mellitus other than gestational diabetes mellitus 2) persons who take diabetic medicine 3) persons whose HbA1c is 6.1% or higher 4) persons who are forbidden to do exercise by doctor 5) persons with pregnancy or possible pregnancy 6) persons who already receive diet and/or exercise recipe other than this study 7) persons with possible type 1 diabetes mellitus 8) persons with a diagnosis of liver cirrhosis or chronic viral hepatitis (type B or type C) 9) persons with cardiac pacemaker 10) persons who are forbidden to participate in this trial by doctor

Design outcomes

Primary

Measure	Time frame
Cumulative incidence of diabetes mellitus.	—

Secondary

Measure	Time frame
Changes of body weight, BMI, waist circumference, blood glucose, HbA1c, blood pressure, lipids, the prevalence of metabolic syndrome, and health behavior.	—

Countries

Japan

Contacts

Public ContactNaoki Sakane

National Hospital Organization Kyoto Medical Center Clinical Research Institute

j-doit1@kyotolan.hosp.go.jp075-641-9161

Outcome results

None listed